Opportunistic infections associated with HIV infection in Africa

Oral Diseases

Volumn 8, Issue SUPPL. 2, 2002, Pages 76-79

  Maartens, G ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Africa; HIV infection; Opportunistic infection

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; COTRIMOXAZOLE; ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

AFRICA; ATYPICAL MYCOBACTERIOSIS; CLINICAL TRIAL; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIALIZATION; MICROSPORIDIOSIS; MORTALITY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SURVIVAL; TUBERCULOSIS; ADULT; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BLACK PERSON; CHILD; CYTOMEGALOVIRUS INFECTIONS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HIV SEROPOSITIVITY; INCIDENCE; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PNEUMONIA, PNEUMOCYSTIS; SERODIAGNOSIS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; AIDS RELATED COMPLEX; ARTICLE; CYTOMEGALIC INCLUSION BODY DISEASE; NEGRO; STATISTICS;

ADULT; AFRICA; AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; AIDS SERODIAGNOSIS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; CHILD; CYTOMEGALOVIRUS INFECTIONS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MICROSPORIDIOSIS; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PNEUMONIA, PNEUMOCYSTIS; SURVIVAL RATE; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION; TUBERCULOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 2942536265     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2002.00016.x     Document Type: Review

References (24)

1. Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L et al (1995). Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS 9: 267-273.
2. Anglaret X, Chene G, Attia A, Toure S, Lafont S, Combe P et al (1999). Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 353: 1463-1468.
3. Batchelor BI, Kimari JN, Brindle RJ (1996). Microbiology of HIV associated bacteraemia and diarrhoea in adults from Nairobi. Kenya Epidemiol Infect 117: 139-144.
4. Benatar SR (1991). Medicine and health care in South Africa - five years later. N Engl J Med 325: 30-36.
5. Chintu C, Dupont HL, Kaile T, Mahmoud M, Marani S, Baboo KS et al (1998). Human immunodeficiency virus-associated diarrhoea and wasting in Zambia: selected risk factors and clinical associations. Am J Trop Med Hyg 59: 38-41.
6. Del Amo J, Petruckevitch A, Phillips AN, Johnson AM, Stephenson JM, Desmond N et al (1996). Spectrum of disease in Africans with AIDS living in London. AIDS 10: 1563-1569.
7. French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K et al (2000). 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 355: 2106-2111.
8. Gilks CF, Ojoo SA, Ojoo JC, Brindle RJ, Paul J, Batchelor BI et al (1996). Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 347: 718-723.
9. Gumbo T, Sarbah S, Gangaidzo IT, Ortega Y, Sterling CR, Carville A et al (1999). Intestinal parasites in patients with diarrhoea and human immunodeficiency virus infection in Zimbabwe. AIDS 13: 819-821.
10. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM et al (1993). The mortality and pathology of HIV infection in a West African city. AIDS 7: 1569-1579.
11. Maartens G (1999). Clinical progression of HIV infection in adults. S Afr Med J 89: 1255-1258.
12. Maartens G, Wood R, O'Keefe E, Byrne C (1997). Independent epidemics of heterosexual and homosexual HIV infection in South Africa -survival differences. Q J Med 90: 449-454.
13. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner HU, Mulder DW et al (1997). HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 350: 245-250.
14. Mwinga A, Hosp M, Godfrey-Faussett P, Quigley M, Mwaba P, Mugala BN et al (1998). Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 12: 2447-2457.
15. Nee EE (1981). Mycobacterium avium complex serovars isolated in South Africa from humans, swine and the environment. Rev Infect Dis 3: 1013-1017.
16. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A (1990). The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 322: 161-165.
17. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P (1997). Tuberculosis and HIV: current status in Africa. AIDS 11 (Suppl. B):S115-S123.
18. Trnka L, Dankova D, Svandova E (1994). Six years experience with the discontinuation of BCG vaccination. 4. Protective effect against the Mycobacterium avium intracellulare complex. Tubercle Lung Dis 75: 348-352.
19. UNAIDS (2000). Report on the Global HIV/AIDS Epidemic June 2000. Joint United Nations Programme on HIV/AIDS, Geneva.
20. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H et al (2000). Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 356: 1051-1056.
21. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C et al (1999). Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 353: 1469-1474.
22. Wilkinson D, Squire SB, Garner P (1998). Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. BMJ 317: 625-629.
23. Yarchoan R, Venzon DJ, Pluda JM, Lietzau J, Wyvill KM, Tsiatis AA et al (1991). CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 115: 184-189.
24. Zar H, Maartens G, Wood R, Hussey G (2000). Pneumocystis carinii pneumonia in HIV-infected patients in Africa - an important pathogen? S Afr Med J 90: 684-688.